Detalles de la búsqueda
1.
Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.
Gut
; 67(6): 1033-1041, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29196436
2.
Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study.
Gut
; 67(6): 1042-1051, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28988197
3.
Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy.
Digestion
; 97(3): 212-218, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29393194
4.
Exploratory Research on Latent Esophageal Motility Disorders in Dysphagia Patients.
Digestion
; 95(4): 269-274, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28395277
5.
Albumin and apolipoprotein H mRNAs in human plasma as potential clinical biomarkers of liver injury: analyses of plasma liver-specific mRNAs in patients with liver injury.
Biomarkers
; 21(4): 353-62, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26901698
6.
Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.
Curr Ther Res Clin Exp
; 81-82: 1-7, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28119763
7.
Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn's disease.
BMC Gastroenterol
; 13: 124, 2014 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25015328
8.
Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
Digestion
; 88(3): 145-52, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24008338
9.
Predictive factors associated with the success of pneumatic dilatation in Japanese patients with primary achalasia: a study using high-resolution manometry.
Digestion
; 87(1): 23-8, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23343965
10.
Endoscopic evaluation of low-dose aspirin-induced gastric and duodenal ulcers during prophylaxis with lansoprazole.
Hepatogastroenterology
; 60(124): 762-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23478070
11.
Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.
Dig Dis Sci
; 56(8): 2333-42, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21302138
12.
[Diagnosis of gastric ulcer in the elderly].
Nihon Rinsho
; 68(11): 2025-9, 2010 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-21061527
13.
The impact of lifestyle modification on the health-related quality of life of patients with reflux esophagitis receiving treatment with a proton pump inhibitor.
Am J Gastroenterol
; 104(5): 1106-11, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19337239
14.
Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
Am J Gastroenterol
; 104(11): 2779-87, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19638966
15.
Characteristics affecting health-related quality of life (HRQOL) in Japanese patients with reflux oesophagitis and the effect of lansoprazole on HRQOL.
J Med Econ
; 12(3): 182-91, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19691444
16.
The safety and effectiveness of vonoprazan-based Helicobacter pylori eradication therapy; a prospective post-marketing surveillance.
Expert Opin Drug Saf
; 18(12): 1255-1261, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31646920
17.
Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study.
Clin Transl Gastroenterol
; 10(11): e00101, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31770139
18.
The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study.
J Gastroenterol
; 43(12): 920-7, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19107335
19.
Obesity as a risk factor for GERD in Japan.
J Gastroenterol
; 43(1): 57-62, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18297437
20.
Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole.
World J Gastroenterol
; 24(14): 1550-1561, 2018 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29662293